The FDA issued a warning letter to Sanofi-Aventis about manufacturing problems at the firm's vaccine production plant in Swiftwater, Pa. Company officials said they were taking the warning "very seriously," while FDA officials said the plant's problems probably would not interfere with Sanofi's production of flu vaccine for the coming season.

Related Summaries